Low Dose Aspirin Alerts in High-Risk Pregnancies

Conditions: Preeclampsia, Aspirin, Clinical Decision Support Systems, Economics, Behavioral

Sex: Female

Healthy volunteers: No

Phase: NA

Enrollment: 830

Sponsor: Geisinger Clinic

Summary

The goal of this study is to assess the effect of an electronic health record (EHR) clinical decision support tool, also known as a best practice alert (BPA), on healthcare provider recommendations for low dose aspirin use in a high-risk pregnant patient population. The investigators hypothesize that the implementation of the EHR BPA tool will increase the healthcare provider's recommendation for low dose aspirin compared to current standard care.

Eligibility Criteria

Inclusion Criteria: * Receiving prenatal care within Geisinger * Initial prenatal visit prior to 28 weeks gestation * Determined to be high risk for preeclampsia based on the modified United States Preventive Services Task Force and American College of Obstetrics and Gynecology criteria (at least 1 high risk factor) Exclusion Criteria: * Not pregnant * No prenatal visit prior to 28 weeks gestation * Maternal-Fetal Medicine only visits * Not meeting the modified USPSTF high-risk criteria * Contraindication to aspirin, including allergy

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05802940). StuddyBuddy aggregates publicly available trial information.